The present study shows for the first time that prenatal to early postnatal treatment with the neurotrophic compound P021 can prevent not only cognitive deficit but also AD-type pathological changes, which include tau and Aβ pathologies, postsynaptic deficit, and neuroinflammation later in life in 3xTg mice. The gene discussed is MAPT; the disease is Alzheimer disease.